Autolus Therapeutics (AUTL) Earnings Date, Estimates & Call Transcripts $1.14 -0.07 (-5.87%) Closing price 03:59 PM EasternExtended Trading$1.14 +0.00 (+0.09%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Autolus Therapeutics Earnings Summary Upcoming Earnings DateMay. 16Before Market OpensEstimatedConsensus EPS (Mar. 20) -$0.21 Actual EPS (Mar. 20) -$0.09 Beat By $0.12 Actual Revenue (Mar. 20) $0.03MAutolus Therapeutics posted Q4 2024 earnings on March 20, 2025, reporting an EPS of -$0.09, which beat the consensus estimate of -$0.21 by $0.12. Quarterly revenue was reported to be $0.03 million, below analysts' expectations of $2.98 million. With a trailing EPS of -$0.86, Autolus Therapeutics' earnings are expected to grow next year, from ($0.94) to ($0.83) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Annual Report (10-K)SEC FilingAUTL Upcoming EarningsAutolus Therapeutics' next earnings date is estimated for Friday, May 16, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Autolus Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autolus Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAUTL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AUTL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Autolus Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.24-$0.24-$0.24Q2 20251-$0.25-$0.25-$0.25Q4 20251-$0.20-$0.20-$0.20 Remove Ads Autolus Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/16/2025(Estimated)--------3/20/2025Q4 2024-$0.21-$0.09+$0.12-$0.09$2.98M$0.03M11/12/2024Q3 2024-$0.21-$0.31 -$0.10-$0.31$0.40M-8/8/2024Q2 2024-$0.19-$0.22 -$0.03-$0.22--5/17/2024Q1 2024-$0.10-$0.24 -$0.14-$0.24$50.00M$10.09M3/14/2024Q4 2023-$0.26-$0.44 -$0.18-$0.44--11/2/2023Q3 2023-$0.24-$0.26 -$0.02-$0.26$2.00M$0.41M8/3/2023Q2 2023-$0.22-$0.26 -$0.04-$0.26--5/4/2023Q1 2023-$0.28-$0.23+$0.05-$0.23$1.09M$1.29M Autolus Therapeutics Earnings - Frequently Asked Questions When is Autolus Therapeutics's earnings date? Autolus Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 16th, 2025 based off last year's report dates. Learn more on AUTL's earnings history. Did Autolus Therapeutics beat their earnings estimates last quarter? In the previous quarter, Autolus Therapeutics (NASDAQ:AUTL) reported ($0.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.12. Learn more on analysts' earnings estimate vs. AUTL's actual earnings. How can I listen to Autolus Therapeutics's earnings conference call? The conference call for Autolus Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Autolus Therapeutics's conference call transcript? The conference call transcript for Autolus Therapeutics's latest earnings report can be read online. Read Transcript How can I view Autolus Therapeutics's earnings report? Autolus Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded annual revenue of $10.12 million. How much profit does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded net income of -$208.38 million. AUTL has generated -$0.86 earnings per share over the last four quarters. What is Autolus Therapeutics's EPS forecast for next year? Autolus Therapeutics's earnings are expected to grow from ($0.94) per share to ($0.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Disc Medicine Earnings Results Travere Therapeutics Earnings Results Schrödinger Earnings Results IDEAYA Biosciences Earnings Results Immunocore Earnings Results Indivior Earnings Results CG Oncology Earnings Results Vera Therapeutics Earnings Results ARS Pharmaceuticals Earnings Results Edgewise Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:AUTL) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Autolus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AUTL Stock Free AUTL Stock Alerts